Equitable Trust CO Glaukos Corp Transaction History

Equitable Trust CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 21, 2020	SELL	$25.53 - $70.14 $114,885 - $315,630	-4,500 Closed	0 $0
Q4 2018 Feb 22, 2019	BUY	$52.18 - $67.93 $26,090 - $33,965	500 Added 12.5%	4,500 $253,000
Q3 2018 Nov 15, 2018	BUY	$38.13 - $68.37 $152,520 - $273,480	4,000 New	4,000 $260,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

Stay updated on Equitable Trust CO with notifications on news.